Literature DB >> 18515780

Asymmetric breast uptake of radioiodine in a patient with thyroid malignancy: metastases or not?

A Sinha1, K M Bradley, J Steatham, A Weaver.   

Abstract

Various physiological processes can cause potentially misleading appearances in radioiodine whole body scans; proper understanding of the causes of these can therefore obviate diagnostic errors. Whole-body radioiodine scintigraphy with I131 or I123 is an accurate form of imaging used for management of differentiated thyroid carcinoma. Following thyroidectomy, any residual thyroid tissue or metastatic disease is ablated with high dose I131 and diagnostic images are acquired, demonstrating residual thyroid tissue and metastatic disease. However, atypical physiological uptake of I131 can simulate metastases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18515780      PMCID: PMC2408632          DOI: 10.1258/jrsm.2008.080040

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  3 in total

1.  99m Tc-pertechnetate scintigraphy as an aid in the diagnosis of breast masses.

Authors:  E T Cancroft; S J Goldsmith
Journal:  Radiology       Date:  1973-02       Impact factor: 11.105

2.  Radioactive iodine uptake by breasts.

Authors:  G R Baeumler; K G Joo
Journal:  J Nucl Med       Date:  1986-01       Impact factor: 10.057

3.  Patterns of radioiodine uptake by the lactating breast.

Authors:  S M Bakheet; M M Hammami
Journal:  Eur J Nucl Med       Date:  1994-07
  3 in total
  2 in total

1.  False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer.

Authors:  Jong-Ryool Oh; Byeong-Cheol Ahn
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

2.  Bilateral breast uptake of radioiodine in a male patient with gynecomastia: A case report.

Authors:  Lebriz Uslu; Mustafa Ozbayrak; Betul Vatankulu; Kerim Sonmezoglu
Journal:  Indian J Nucl Med       Date:  2015 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.